(Published in Part II, Section 3, Sub Section (ii) of the
Gazette of India Extraordinary, dated the 16th September, 2005)
Government of India
Ministry of Chemicals and Fertilizers
(National Pharmaceuticals Pricing Authority)
New Delhi, the 16th September, 2005
ORDER
S.O.1337(E) – In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:
TABLE
| Sl. No. | Name of the Formulation | Strength | Pack Size | Ceiling Price (Rs.) |
|---|---|---|---|---|
| (1) | (2) | (3) | (4) | (5) |
-- |
Each ml contains | -- |
||
| 1 | Ranitidine Injection | Ranitidine Hcl eq. to Ranitidine – 50mg | 2ml Ampoule | 2.70 |
| 2 | Ranitidine+Ondansetron Injection | Ranitidine Hcl eq. to Ranitidine – 25mg Ondansetron -2mg |
2ml Ampoule | 2.72 |
-- |
Each coated / uncoated tablets Contains | -- |
||
| 3 | Ranitidine+Domperidone Tablets | Ranitidine Hcl eq. to Ranitidine – 150 mg Domperidon -15mg |
10’s Strip/Blister | 5.16 |
| 4 | Ranitidine+Drotaverine Tablets | Ranitidine Hcl eq. to Ranitidine – 150 mg Drotaverine Hcl -40mg |
10’s Strip/Blister | 11.60 |
| 5 | Ranitidine+Ondansetron Tablets | Ranitidine Hcl eq. to Ranitidine – 150 mg Ondansetron-4mg |
10’s Strip/Blister | 5.72 |
| 6 | Ranitidine+Dicyclomine +Clidinium Bromide Tablets |
Ranitidine Hcl eq. to Ranitidine – 150 mg Dicyclomine Hcl -10mg Clidinium Bromide -2.5mg |
10’s Strip/Blister | 5.32 |
| 7 | Ranitidine+ Magaldrate Tablets | Ranitidine Hcl eq. to Ranitidine – 150 mg Magaldrate -200mg |
10’s Strip/Blister | 4.34 |
| 8 | Ranitidine+Domperidone Tablets | Ranitidine Hcl eq. to Ranitidine – 150 mg Domperidone -20mg |
10’s Strip/Blister | 5.46 |
| 9 | Ranitidine+ Domperidon+ + Magaldrate Tablets |
Ranitidine Hcl eq. to Ranitidine – 150 mg Domperidon -10mg Magaldrate -400mg |
10’s Strip/Blister | 5.76 |
-- |
Each dispersible tablets Contains | -- |
||
| 10 | Ranitidine Tablets | Ranitidine Hcl eq. to Ranitidine – 75 mg | 10’s Al_St | 7.52 |
| 11 | Ranitidine Tablets | Ranitidine Hcl eq. to Ranitidine – 75 mg | 10’s Al_Bl | 7.16 |
NOTE :
(a) The prices fixed are the maximum ceiling prices (exclusive of excise duty and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) Pro-rata pricing for packs of same composition but of different sizes, will be applicable vide S.O. No. 83(E) dated 27.1.1998.
(c) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
PN/82/2005/F
F. No. 8(9)/2005/D.P./NPPA-Div.II
(A. K. PAL)
Deputy Director
National Pharmaceutical Pricing Authority
Last Page Updated: 07-06-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)